Sandrine Egron
Investment Director / Principal
Works at Impactivist (ex Investir&+)
Investor profile | Builders Republic
About
Investment Director at Impactivist (formerly Investir&+), Sandrine Egron invests in Seed and Series A with check sizes ranging from €0.2 to €2.5 million, with a specialized thesis in health and medtech covering digital health, diagnostics, and telemedicine. Her expertise is based on a dense operational background: R&D manager in medical devices at RWTH Aachen University, co-founder of Vivosim and then InnYTe, before joining 50 Partners Health. Her track record includes notably Ensweet (tele-rehabilitation) and En Carta Diagnostics, where she sits on the board. She holds a PhD from RWTH Aachen University and graduated from Centrale Lyon.
Profile
- Role
- Investment Director / Principal
- Fund
- Impactivist (ex Investir&+)
- Nationality
- French